샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514925

파상풍 톡소이드 백신 시장 : 유형별, 형태별, 유통별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Tetanus Toxoid Vaccine Market, By Type, By Form, By Distribution, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 387 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

파상풍 톡소이드 백신 시장 규모는 2023년 49억 8,678만 달러로 2024년부터 2032년까지 연평균 5.9% 성장할 것으로 예상됩니다.

파상풍 톡소이드 백신 시장 - 시장 역학

파상풍 톡소이드 백신에 대한 인지도 향상과 정부의 노력으로 시장 성장 견인

파상풍 톡소이드 백신 시장은 전 세계적인 인식 개선과 정부의 노력에 힘입어 크게 성장하고 있습니다. 예를 들어, 세계보건기구(WHO)와 미국 질병통제예방센터(CDC)와 같은 조직은 파상풍 백신 접종을 예방접종 프로그램의 중요한 요소로 적극적으로 홍보하여 대중의 인식 개선에 기여하고 있습니다. 또한, 인도와 나이지리아 등의 정부는 파상풍을 효과적으로 퇴치하기 위해 사회적 약자와 농촌 지역을 대상으로 종합적인 예방접종 캠페인을 실시하고 있습니다. 유니세프 데이터에 따르면, 출생 시 영유아의 파상풍 톡소이드 백신 접종률은 2000년 74%에서 2020년 86%로 증가했으며, 이는 백신 접종률을 확대하기 위한 협력적 노력의 영향을 반영합니다. 이러한 이니셔티브는 파상풍 톡소이드 백신 시장의 성장을 촉진하는 데 있어 인식 제고와 정부 지원이 매우 중요한 역할을 한다는 점을 강조하고 있습니다.

파상풍 톡소이드 백신 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 매년 약 5.9%의 CAGR로 성장할 것으로 예상됩니다.

유형별로는 혼합 백신이 2023년 가장 큰 시장 점유율을 보일 것으로 예측되었습니다.

형태별로는 2023년 동결건조 백신이 주요 유형으로 나타났습니다.

유통 부문별로는 2023년 병원 약국이 주요 유형으로 부상했습니다.

지역별로는 북미가 2023년 매출에서 선두를 차지했습니다.

파상풍 톡소이드 백신 시장 - 세분화 분석:

파상풍 톡소이드 백신 세계 시장은 유형, 형태, 유통, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 종류에 따라 일가 파상풍 톡소이드 백신과 혼합 백신으로 나뉩니다. 혼합 백신은 하나의 제제로 여러 질병을 예방할 수 있어 편리성이 높습니다. 일가 파상풍 톡소이드 백신은 파상풍 감염에 대한 표적 면역으로 특정 백신 접종 요구에 대응하고 있습니다.

시장은 제형에 따라 액체 백신과 동결건조 백신의 두 가지 범주로 나뉩니다. 동결건조 백신은 액체 제형에 비해 안정성이 높고 보관 기간이 길기 때문에 주류로 자리 잡았습니다. 액상백신이 그 뒤를 이어 투여의 편리함을 제공하지만 효능을 유지하기 위해서는 신중한 보관과 취급이 필요합니다.

파상풍 톡소이드 백신 시장 - 지리적 인사이트

미국, 유럽 국가 등 의료 인프라가 잘 갖춰진 선진국에서는 예방접종 프로그램이 잘 구축되어 있고 규제 체계가 엄격하기 때문에 백신 접종률이 높습니다. 반면 아시아태평양과 아프리카의 신흥국들은 백신의 입수, 보관 및 유통 인프라에 대한 도전에 직면하여 백신 접종률에 영향을 미치고 있습니다. 그러나 정부 이니셔티브와 국제기구와의 협력을 통해 이들 지역에서는 백신 접근성과 접종률을 높이기 위한 노력이 진행되고 있습니다. 또한, 동남아시아, 사하라 이남 아프리카 등 자연재해와 인도주의적 위기가 발생하기 쉬운 지역에서는 취약 계층의 파상풍 발병을 예방하기 위해 표적 예방접종 캠페인이 종종 실시되고 있습니다.

파상풍 톡소이드 백신 시장 - 경쟁 상황:

파상풍 톡소이드 백신 시장의 경쟁 구도는 GSK, 사노피 파스퇴르, 머크(Merck &Co., Inc.)와 같은 주요 기업들이 광범위한 백신 포트폴리오와 세계 진출로 시장을 독점하고 있는 것이 특징입니다. 이들 기업은 강력한 R&D 역량, 규제 관련 전문 지식, 제조 역량을 활용하여 시장 리더십을 유지하고 있습니다. 또한, 정부 기관, 국제기구 및 비영리 단체와의 전략적 제휴를 통해 시장 입지를 강화하고 전 세계 백신 접종 프로그램에 쉽게 접근할 수 있도록 돕고 있습니다. 또한, 신생 기업 및 지역 백신 제조업체들은 특정 지역에 맞는 비용 효율적인 대체품이나 틈새 백신 제제를 제공함으로써 시장 경쟁에 기여하고 있습니다. 백신 생산 및 유통의 기술 발전과 백신 개발 투자 증가로 파상풍 톡소이드 백신 시장의 경쟁은 더욱 치열해지고 있습니다.

목차

제1장 파상풍 톡소이드 백신 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 파상풍 톡소이드 백신의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 파상풍 톡소이드 백신 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 파상풍 톡소이드 백신 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 파상풍 톡소이드 백신 시장 상황

  • 파상풍 톡소이드 백신 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 파상풍 톡소이드 백신 시장 : 유형별

  • 개요
    • 부문 점유율 분석
    • 1가 파상풍 톡소이드 백신
    • 혼합 백신

제8장 파상풍 톡소이드 백신 시장 : 형태별

  • 개요
    • 부문 점유율 분석
    • 액체
    • 동결건조

제9장 파상풍 톡소이드 백신 시장 : 유통별

  • 개요
    • 부문 점유율 분석
    • 병원 약국
    • 소매 약국
    • 온라인 약국
    • 정부 공급업체

제10장 파상풍 톡소이드 백신 시장 : 최종사용자별

  • 개요
    • 부문 점유율 분석
    • 병원
    • 클리닉
    • 공중위생 기관
    • 재택 케어 환경

제11장 파상풍 톡소이드 백신 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 파상풍 톡소이드 백신 업계

  • 경쟁 대시보드
  • 기업 개요
    • Astellas Pharma Inc.
    • Bharat Biotech International Limited
    • Biological E. Limited
    • China National Pharmaceutical Group Corporation
    • Emergent BioSolutions Inc.
    • GlaxoSmithKline Biologicals SA
    • Indian Immunologicals Limited
    • Lupin Limited
    • Merck Sharp &Dohme Corp.
    • Mitsubishi Tanabe Pharma Corporation
    • Novartis Vaccines and Diagnostics, Inc.
    • Panacea Biotec Limited
    • Pfizer Inc.
    • Sanofi Pasteur Inc.
    • Serum Institute of India Pvt. Ltd.
    • Shenzhen Kangtai Biological Products Co., Ltd.
    • Others

제13장 애널리스트의 전방위 전망

ksm 24.07.24

REPORT HIGHLIGHT

The Tetanus Toxoid Vaccine Market size was valued at USD 4,986.78 million in 2023, expanding at a CAGR of 5.9% from 2024 to 2032.

The Tetanus Toxoid Vaccine Market involves the production and distribution of vaccines designed to provide immunity against tetanus, a potentially deadly bacterial infection. The continued focus on immunization programs worldwide, growing awareness about the importance of vaccination, and the inclusion of tetanus toxoid vaccines in routine immunization schedules are driving the market growth. However, restraints include challenges related to vaccine storage and distribution in remote or low-resource settings, as well as concerns about vaccine safety and efficacy. Market opportunities lie in expanding access to vaccination in emerging economies, advancements in vaccine technology to improve storage stability, and the development of combination vaccines for broader protection against multiple diseases.

Tetanus Toxoid Vaccine Market- Market Dynamics

Rising Awareness and Government Initiatives Drive Tetanus Toxoid Vaccine Market Growth

The Tetanus Toxoid Vaccine Market is experiencing significant growth propelled by increasing awareness and government initiatives worldwide. For example, organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) actively promote tetanus vaccination as a crucial component of immunization programs, contributing to heightened public awareness. Furthermore, governments in countries such as India and Nigeria have implemented comprehensive vaccination campaigns, targeting vulnerable populations and rural areas to combat tetanus effectively. According to data from UNICEF, global coverage of tetanus toxoid vaccination for infants at birth increased from 74% in 2000 to 86% in 2020, reflecting the impact of concerted efforts to expand vaccination coverage. These initiatives underscore the pivotal role of raising awareness and government support in driving the growth of the Tetanus Toxoid Vaccine Market.

Tetanus Toxoid Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.9% over the forecast period (2024-2032)

Based on Type segmentation, Combination Vaccines were predicted to show maximum market share in the year 2023

Based on Form segmentation, Lyophilized was the leading type in 2023

Based on distribution segmentation, Hospital Pharmacies was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Tetanus Toxoid Vaccine Market- Segmentation Analysis:

The Global Tetanus Toxoid Vaccine Market is segmented based on Type, Form, Distribution, End-User, and Region.

The market is divided into two categories based on Type: Monovalent Tetanus Toxoid Vaccines and Combination Vaccines. Combination vaccines as the dominant segment, offering convenience and broader protection against multiple diseases in a single formulation. Monovalent tetanus toxoid vaccines follow, serving specific vaccination needs with targeted immunization against tetanus infection.

The market is divided into two categories based on Form: Liquid and Lyophilized. Lyophilized vaccines are the predominant segment, offering enhanced stability and longer shelf life compared to liquid formulations. Liquid vaccines follow, providing convenience in administration but requiring careful storage and handling to maintain efficacy.

Tetanus Toxoid Vaccine Market- Geographical Insights

Developed countries with robust healthcare infrastructures, such as the United States and European nations, exhibit high vaccination coverage rates due to well-established immunization programs and stringent regulatory frameworks. In contrast, emerging economies in Asia-Pacific and Africa face challenges related to vaccine accessibility, storage, and distribution infrastructure, impacting vaccination coverage rates. However, government initiatives and collaborations with international organizations are driving efforts to improve vaccine access and coverage in these regions. Moreover, regions prone to natural disasters or humanitarian crises, such as Southeast Asia and Sub-Saharan Africa, often witness targeted vaccination campaigns to prevent tetanus outbreaks among vulnerable populations.

Tetanus Toxoid Vaccine Market- Competitive Landscape:

The competitive landscape of the Tetanus Toxoid Vaccine Market is characterized by the presence of key players such as GSK, Sanofi Pasteur, and Merck & Co., Inc., dominating the market with their extensive vaccine portfolios and global reach. These companies leverage their strong research and development capabilities, regulatory expertise, and manufacturing capacities to maintain their market leadership. Additionally, strategic collaborations with government agencies, international organizations, and non-profit entities bolster their market presence and facilitate access to vaccination programs worldwide. Moreover, emerging players and regional vaccine manufacturers contribute to market competition by offering cost-effective alternatives and niche vaccine formulations tailored to specific geographical regions. Technological advancements in vaccine production and distribution, along with increasing investments in vaccine development, further intensify competition in the Tetanus Toxoid Vaccine Market.

Recent Developments:

In August 2022, IBSS Biomed S.A. initiated a clinical trial to evaluate the efficacy and safety of CLODIVAC, it's bivalent tetanus and diphtheria vaccine, as a booster immunization alongside Sanofi Pasteur's Td-Impfstoff Merieux, targeting healthy adults.

In August 2022, Madhya Pradesh, India's Public Health and Family Welfare Minister inaugurated the state-level DPT/TD vaccination campaign at the Kamala Nehru Girls School Auditorium in Bhopal, aiming to promote immunization against diphtheria, pertussis, and tetanus.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TETANUS TOXOID VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Astellas Pharma Inc.

Bharat Biotech International Limited

Biological E. Limited

China National Pharmaceutical Group Corporation

Emergent BioSolutions Inc.

GlaxoSmithKline Biologicals S.A.

Indian Immunologicals Limited

Lupin Limited

Merck Sharp & Dohme Corp.

Mitsubishi Tanabe Pharma Corporation

Novartis Vaccines and Diagnostics, Inc.

Panacea Biotec Limited

Pfizer Inc.

Sanofi Pasteur Inc.

Serum Institute of India Pvt. Ltd.

Shenzhen Kangtai Biological Products Co., Ltd.

Others

GLOBAL TETANUS TOXOID VACCINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monovalent Tetanus Toxoid Vaccine
  • Combination Vaccines

GLOBAL TETANUS TOXOID VACCINE MARKET, BY FORM- MARKET ANALYSIS, 2019 - 2032

  • Liquid
  • Lyophilized

GLOBAL TETANUS TOXOID VACCINE MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Government Suppliers

GLOBAL TETANUS TOXOID VACCINE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Public Health Agencies
  • Homecare Settings

GLOBAL TETANUS TOXOID VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tetanus Toxoid Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tetanus Toxoid Vaccine Market Snippet by Type
    • 2.1.2. Tetanus Toxoid Vaccine Market Snippet by Form
    • 2.1.3. Tetanus Toxoid Vaccine Market Snippet by Distribution
    • 2.1.4. Tetanus Toxoid Vaccine Market Snippet by End-User
    • 2.1.5. Tetanus Toxoid Vaccine Market Snippet by Country
    • 2.1.6. Tetanus Toxoid Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Tetanus Toxoid Vaccine Key Market Trends

  • 3.1. Tetanus Toxoid Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tetanus Toxoid Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tetanus Toxoid Vaccine Market Opportunities
  • 3.4. Tetanus Toxoid Vaccine Market Future Trends

4. Tetanus Toxoid Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tetanus Toxoid Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tetanus Toxoid Vaccine Market Landscape

  • 6.1. Tetanus Toxoid Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tetanus Toxoid Vaccine Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Monovalent Tetanus Toxoid Vaccine
    • 7.1.3. Combination Vaccines

8. Tetanus Toxoid Vaccine Market - By Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Form, 2023 & 2032 (%)
    • 8.1.2. Liquid
    • 8.1.3. Lyophilized

9. Tetanus Toxoid Vaccine Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies
    • 9.1.5. Government Suppliers

10. Tetanus Toxoid Vaccine Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Public Health Agencies
    • 10.1.5. Homecare Settings

11. Tetanus Toxoid Vaccine Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Tetanus Toxoid Vaccine Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Tetanus Toxoid Vaccine Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Tetanus Toxoid Vaccine Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Tetanus Toxoid Vaccine Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Tetanus Toxoid Vaccine Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Tetanus Toxoid Vaccine Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Astellas Pharma Inc.
    • 12.2.2. Bharat Biotech International Limited
    • 12.2.3. Biological E. Limited
    • 12.2.4. China National Pharmaceutical Group Corporation
    • 12.2.5. Emergent BioSolutions Inc.
    • 12.2.6. GlaxoSmithKline Biologicals S.A.
    • 12.2.7. Indian Immunologicals Limited
    • 12.2.8. Lupin Limited
    • 12.2.9. Merck Sharp & Dohme Corp.
    • 12.2.10. Mitsubishi Tanabe Pharma Corporation
    • 12.2.11. Novartis Vaccines and Diagnostics, Inc.
    • 12.2.12. Panacea Biotec Limited
    • 12.2.13. Pfizer Inc.
    • 12.2.14. Sanofi Pasteur Inc.
    • 12.2.15. Serum Institute of India Pvt. Ltd.
    • 12.2.16. Shenzhen Kangtai Biological Products Co., Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제